Stuart Lipsitz, ScD
Director of Biostatistical Services, CSPH
Stuart Lipsitz, ScD, is the head of Biostatistical Services at the Center for Surgery and Public Health (CSPH) at Brigham and Women's Hospital, a position he assumed in 2005. Dr Lipsitz actively collaborates with the faculty and fellows at the CSPH, and is the lead biostatician on the CSPH grant, "The Comparative Effectiveness of Provider Induced Demand Collaboration," funded by the Department of Defense. Dr. Lipsitz is currently a Full Professor at Brigham and Women's Hospital (BWH) and Harvard Medical School. In addition to collaborating with investigators at the CSPH at BWH, he also collaborates with investigators in the BWH Division of General Medicine and at Ariadne Labs, a new joint center for health systems innovation at BWH and the Harvard School of Public Health.
Dr. Lipsitz has been very active in both biostatistical methods and collaborative research, having been a co-author on over 400 publications. His expertise is in biostatistics, with a background in collaborations on health services and outcomes research from surgical procedures, approaches to improve medication safety and reduce surgical complication, medical malpractice studies, cancer, diabetes, health disparities, cardiovascular studies, and AIDS. In biostatistics, his research involves of a wide assortment of new statistical methods, including methods for analyzing complex sample survey data, repeated measures (and longitudinal) studies, survival studies, clinical trials, studies with missing data, and studies with categorical endpoints. He has more than 100 publications in top statistical journals.
An example of the impact of Dr. Lipsitz's involvement in collaborations was a pre-post study designed to assess the ability of a 19-item surgical safety checklist in reducing complications and deaths in eight hospitals around the world. Using a new approach to calculate standardized complication rates for clustered data (where hospitals formed the clusters) developed by Dr. Lipsitz, the study found that the checklist reduced inpatient complications from 11% to 7%. These results were reported in the New England Journal of Medicine in January of 2009. This is a very highly cited paper, with 2170 citations according to Google Scholar in the last 5 years alone.
Dr. Lipsitz received his ScD degree in Biostatistics at Harvard University, and completed Post-Doctoral Fellowships at Harvard School of Public Health and Dana-Farber Cancer Institute. He has previously held faculty appointments at the Harvard School of Public Health, the Dana-Farber Cancer Institute, and the Medical University of South Carolina.
Visit the link below to view the statistical software and published/working manuscripts for the grant "Analyzing National Complex Sample Surveys for Epidemiologic Studies of Cancer":
Dr. Lipsitz's Researcher Profile and Publications
This page was last modified on 9/18/2015